Synergy between amyloid-β and tau in Alzheimer’s disease-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Synergy between amyloid-β and tau in Alzheimer’s disease

Published:2020-08-10 Issue:10 Volume:23 Page:1183-1193
ISSN:1097-6256
Container-title:Nature Neuroscience
language:en
Short-container-title:Nat Neurosci

Author:

Busche Marc Aurel^ORCID,Hyman Bradley T.^ORCID

Funder

RCUK | Medical Research Council

BrightFocus Foundation

U.S. Department of Health & Human Services | NIH | National Institute on Aging

JPB Foundation

Tau Consortium

Publisher

Springer Science and Business Media LLC

Subject

General Neuroscience

Link

https://www.nature.com/articles/s41593-020-0687-6.pdf

Reference150 articles.

1. Arriagada, P. V., Growdon, J. H., Hedley-Whyte, E. T. & Hyman, B. T. Neurofibrillary tangles but not senile plaques parallel duration and severity of Alzheimer’s disease. Neurology 42, 631–639 (1992).

2. Ingelsson, M. et al. Early Abeta accumulation and progressive synaptic loss, gliosis, and tangle formation in AD brain. Neurology 62, 925–931 (2004).

3. Lleó, A., Berezovska, O., Growdon, J. H. & Hyman, B. T. Clinical, pathological, and biochemical spectrum of Alzheimer disease associated with PS-1 mutations. Am. J. Geriatr. Psychiatry 12, 146–156 (2004).

4. Ryan, N. S. et al. Clinical phenotype and genetic associations in autosomal dominant familial Alzheimer’s disease: a case series. Lancet Neurol. 15, 1326–1335 (2016).

5. Hyman, B. T. Amyloid-dependent and amyloid-independent stages of Alzheimer disease. Arch. Neurol. 68, 1062–1064 (2011).

Cited by 707 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Recent advances in nanoenzymes for Alzheimer's disease treatment;Colloids and Surfaces B: Biointerfaces;2024-12

2. Low-dose diazepam improves cognitive function in APP/PS1 mouse models: Involvement of AMPA receptors;Brain Research;2024-12

3. Unveiling the link between glymphatic function and cortical microstructures in post-traumatic stress disorder;Journal of Affective Disorders;2024-11

4. Revolutionizing neurotherapeutics: Nanocarriers unveiling the potential of phytochemicals in Alzheimer's disease;Neuropharmacology;2024-11

5. Implications of liquid-liquid phase separation and ferroptosis in Alzheimer's disease;Neuropharmacology;2024-11

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3